Get the Stockscreener App
0.65
8.41%
-0.0597
After Hours:
.64
-0.01
-1.54%
Envveno Medical Corporation stock is traded at $0.65, with a volume of 167.44K.
It is down -8.41% in the last 24 hours and down -32.85% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$0.7097
Open:
$0.681
24h Volume:
167.44K
Relative Volume:
0.17
Market Cap:
$12.51M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-0.3023
EPS:
-2.15
Net Cash Flow:
$-17.78M
1W Performance:
-8.96%
1M Performance:
-32.85%
6M Performance:
-81.69%
1Y Performance:
-80.83%
1-Day Range:
$0.6318
$0.7096
1-Week Range:
$0.6198
$0.7499
52-Week Range:
$0.6198
$5.62
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
0.65 | 14.35M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
125.80 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.84 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.61 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.42 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Envveno Medical Corporation Stock (NVNO) Latest News
Will enVVeno Medical Corporation (5HJ) stock profit from fiscal stimulusJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - newser.com
Can enVVeno Medical Corporation stock maintain growth trajectoryOptions Play & Safe Capital Investment Plans - newser.com
Visualizing enVVeno Medical Corporation stock with heatmaps2025 Technical Patterns & Fast Entry Momentum Alerts - newser.com
How to use a screener to detect enVVeno Medical Corporation breakouts2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
enVVeno Medical Corporation stock prediction for this weekWeekly Stock Analysis & Risk Managed Investment Strategies - newser.com
Can enVVeno Medical Corporation stock deliver strong Q4 earningsPortfolio Value Report & Low Drawdown Investment Strategies - newser.com
What Wall Street predicts for enVVeno Medical Corporation stock pricePortfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
Quantitative breakdown of enVVeno Medical Corporation recent moveForecast Cut & Stock Market Timing Techniques - newser.com
Why analysts maintain buy rating on enVVeno Medical Corporation (5HJ) stockBear Alert & Safe Entry Point Identification - newser.com
Published on: 2025-11-03 07:21:33 - newser.com
Price momentum metrics for enVVeno Medical Corporation explained2025 Volatility Report & Stock Portfolio Risk Control - newser.com
Tools to monitor enVVeno Medical Corporation recovery probabilityJuly 2025 Market Mood & Fast Exit Strategy with Risk Control - newser.com
enVVeno Medical Corporation stock trend forecast2025 Volatility Report & Free Technical Confirmation Trade Alerts - newser.com
Detecting support and resistance levels for enVVeno Medical Corporation2025 Price Momentum & AI Forecasted Entry and Exit Points - newser.com
Comparing enVVeno Medical Corporation in custom built stock radarsMarket Trend Review & Fast Exit Strategy with Risk Control - newser.com
Will enVVeno Medical Corporation (5HJ) stock justify high valuation2025 Technical Patterns & Smart Investment Allocation Insights - newser.com
Can enVVeno Medical Corporation stock sustain market leadershipWeekly Trade Summary & Growth Oriented Trading Recommendations - newser.com
Will enVVeno Medical Corporation (5HJ) stock benefit from Fed rate cuts2025 Key Lessons & AI Driven Stock Price Forecasts - newser.com
enVVeno Medical Launches $50M Equity Offering Program - The Globe and Mail
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Lelezard
enVVeno Medical reports Q3 EPS (23c) vs. (35c) last year - MSN
NVNO: Financial Stability as FDA Discussions Progress - GuruFocus
enVVeno Medical (NASDAQ: NVNO) funds operations through Q2 2027; cash $31.0M - Stock Titan
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):